CANF Competitors & Alternatives
Compare Can Fite Biopharma Ltd ADR with similar stocks in the same industry
Biotechnology
CANF
Main Stock$3.26
Tradestie Score
53
Market Cap
$9.67M
Revenue Growth
-0.4%
Analyst Upside
+774.2%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$9.88
|
$133.50M | - | 47 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.80
|
$110.20M | - | 54 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$34.48
|
$76.55M | - | 53 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.34
|
$71.69M | - | 55 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.99
|
$67.94M | - | 51 | Compare |
|
BLRX
BioLineRX Ltd
|
$2.80
|
$16.50M | - | 51 | Compare |
|
RDHL
Redhill Biopharma Ltd.
|
$0.93
|
$8.39M | - | 50 | Compare |
|
CETX
CEMTREX INC.
|
$0.77
|
$4.26M | 0.0 | 52 | Compare |
|
HEPA
HEPA
|
- | - | - | - | Compare |
|
CFOR
CFOR
|
- | - | - | - | Compare |
More CANF Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry